|
|
Experience on the clinical effects of Modified Huangqi Guizhi Wuwu Decoction in the treatment of rhabdomyolysis caused by crayfish |
CHE Yueni SHENG Meixiao |
Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210029, China |
|
|
Abstract Rhabdomyolysis (RM) is a series of clinical syndromes, the dissolution of muscle cells caused by striated muscle injury releases plenty of myoglobin, creatine phosphokinase and lactate dehydrogenase, which enter the peripheral blood and give rise to organic biochemical disorder and injury of organ function. RM caused by eating crayfish is also called as Haff disease, which belongs to Chinese medicine “muscle bi-disease”, muscle bi-disease is caused by improper diet, dysfunction of spleen in transportation, dampness blocking channel. Huangqi Guizhi Wuwu Decoction is from Synopsis of Golden Chamber, which is made up of Radix Astragali seu Hedysari, Ramulus Cinnamomi, Radix Paeoniae Alba, Fructus Jujubae. The author uses Modified Huangqi Guizhi Wuwu Decoction in the treatment of RM caused by crayfish on basis of conventional treatment of western medicine, which has achieved satisfactory effects.
|
|
|
|
|
[1] Silkstone GG,Silkstone RS,Simons M,et al. Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design [J]. Biochem J,2016,473(19):3371-3383.
[2] Yang WX,Fan KL,Leung LP. A cluster of patients with rhabdomyolysis after eating crayfish [J]. Cjem,2017,12:1-3.
[3] Zutt R,Van AJ,Linthorst GE,et al. Rhabdomyolysis:review of the literature [J]. Neuromuscul Disord,2014,24(8):651-659.
[4] Toth PP,Patti AM,Giglio RV,et al. Management of statin intolerance in 2018:still more questions than answers [J]. Am J Cardiovasc Drugs,2018,18(3):157-173.
[5] Chan TY. The emergence and epidemiology of Haff disease in China [J]. Toxins,2016,8(12):359.
[6] Vanholder R,Sever MS,Erek E,et al. Rhabdomyolysis [J]. J Am Soc Nephrol,2000,11(8):1553-1561.
[7] Panizo N,Rubio-Navarro A,Amaro-Villalobos JM,et al. Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury [J]. Kidney Blood Press Res,2015,40(5):520-532.
[8] Cervellin G,Comelli I,Benatti M,et al. Non-traumatic rhabdomyolysis:Background,laboratory features,and acute clinical management [J]. Clin Biochem,2017,50(12):656-662.
[9] Zimmerman JL,Shen MC. Rhabdomyolysis [J]. Chest,2013, 144(3):1058-1065.
[10] 霍赛楠,付旷.横纹肌溶解症的影像学诊断进展[J].黑龙江医学,2015,39(4):344-346.
[11] Geng Y,Zhang L,Fu B,et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages [J]. Stem Cell Res Ther,2014,5(3):1-14.
[12] Helmy MM,El-Gowelli HM. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production [J]. Eur J Pharmacol,2012,683(1-3):294-300.
[13] Almeida DC,Donizettioliveira C,Barbosacosta P,et al. In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury [J]. Clin Biochem Rev,2013,34(3):131-144.
[14] 黄德慧,凌军.黄芪桂枝五物汤验案举隅[J].世界中西医结合杂志,2014,49(10):768.
[15] 代民涛,柴可夫,李秀月.《金匮要略》桂枝汤类方治虚劳刍议[J].内蒙古中医药,2013,32(23):129.
[16] 马宁,李凤琴,李宁,等.食源性横纹肌溶解综合征概述[J].中国食品卫生杂志,2010,22(6):564-567.
[17] 孙桂菊.哈夫病与食品安全[J].东南大学学报:医学版,2010,29(6):699-701.
[18] Long S,Garrett J,Bhargava P,et al. Multimodality imaging findings in rhabdomyolysis and a brief review of differential diagnoses [J]. Emerg Radiol,2017,24(4):387-392.
[19] 徐顺娟,窦莉,奚肇庆,等.食源性横纹肌溶解症的中医辨证思维[J].时珍国医国药,2017,28(7):1716-1717.
[20] 芮艳霞.32例横纹肌溶解症临床分析[J].中国现代医生,2017,55(9):64-67.
[21] 朱玮玮,陈继红,刘利华,等.健脾益肾解毒法治疗食源性横纹肌溶解症的疗效观察[J].中医药导报,2017,23(17):95-96. |
|
|
|